Advances in mammalian target of rapamycin kinase inhibitors: application to devices used in the treatment of coronary artery disease

Mammalian target of rapamycin (mTOR) inhibitors have been applied to vascular coronary devices to avoid neointimal growth and have become the predominant pharmacological agents used to prevent restenosis. mTOR inhibitors can affect not only proliferating vascular smooth muscle cells but also endothe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Future Med Chem
Main Authors: Jinnouchi, Hiroyuki, Guo, Liang, Sakamoto, Atsushi, Sato, Yu, Cornelissen, Anne, Kawakami, Rika, Mori, Masayuki, Torii, Sho, Kuntz, Salome, Harari, Emanuel, Mori, Hiroyoshi, Fuller, Daniela, Gadhoke, Neel, Fernandez, Raquel, Paek, Ka Hyun, Surve, Dipti, Romero, Maria, Kolodgie, Frank D, Virmani, Renu, Finn, Aloke V
Formato: Artigo
Idioma:Inglês
Publicado em: Newlands Press Ltd 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333590/
https://ncbi.nlm.nih.gov/pubmed/32431177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc-2019-0304
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados